Our Clients
photo credit: John-Michael Maas / Darby Communications
Our Clients
GHS is an international consulting firm with a portfolio of clients from the public, private and not-for-profit sectors. Working with many of the world’s foremost health organizations, GHS' past and current clients include amfAR, the International Partnership for Microbicides, the Rockefeller Foundation, Aeras Global TB Vaccine Foundation, the Bill & Melinda Gates Foundation, GlaxoSmithKline Biologicals, and QIAGEN. GHS has a strong background in the areas of communications, resource mobilization, research and policy analysis, advocacy, and strategic development.
amFAR,The Foundation for AIDS Research
Founded in 1985, amfAR is dedicated to ending the global AIDS epidemic through innovative research.
GSK is one of the world's leading vaccine manufacturers, supplying around 25% of the world's vaccines.
The mission of the Hib Initiative is to expedite and sustain evidence-informed decisions regarding the use of Hib vaccination, in order to prevent childhood meningitis and pneumonia.
QIAGEN is the leading provider of sample and assay technologies. Sample technologies are used to isolate DNA, RNA and proteins from any biological sample.
The Aeras Global TB Vaccine Foundation
The Aeras Global TB Vaccine Foundation is a non-profit Product Development Partnership (PDP) dedicated to the development of effective TB vaccine regimens that will prevent tuberculosis in all age groups and will be affordable, available and adopted worldwide.
The Bill & Melinda Gates Foundation
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives.
The Biotechnology Industry Organization
BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. Our mission is to be the champion of biotechnology and the advocate for our member organizations—both large and small.
The International AIDS Vaccine Initiative (IAVI)
IAVI’s mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. IAVI is a global not-for-profit, public-private partnership working to accelerate the development of a vaccine to prevent HIV infection and AIDS.
The International Partnership for Microbicides (IPM)
IPM is a non-profit product development partnership (PDP) established in 2002 to prevent HIV transmission by accelerating the development and availability of a safe and effective microbicide for use by women in developing countries.
The work of the Rockefeller Foundation for the 21st Century is to enable 'smart globalization.' It attempts to harness the creative forces of globalization to ensure that the tools and technologies that have significantly improved the human condition in many parts of the world during the past half century are accessible today to more people, more fully, in more places.
Women Deliver is a global advocacy organization bringing together voices from around the world to call for action against maternal death.
